Namoc, Lolita U.

HRN: 03-17-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
CEFTRIAXONE 1G (VIAL)
07/17/2024
07/24/2024
IVT
2g
OD
UTI
Waiting Final Action 
07/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/19/2024
07/19/2024
IV
4.5gm
LD
Septicemia
Waiting Final Action 
07/19/2024
AZITHROMYCIN 500MG TABLET (TAB)
07/19/2024
07/25/2024
PO
500mg
OD
Cap
Waiting Final Action 
07/19/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/19/2024
07/25/2024
IV
2.25gm
Q6
Cap Septicemia
Waiting Final Action 
07/22/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/22/2024
07/29/2024
IVT
600mg
Q8
Infected Would Right Foot
Waiting Final Action 
07/31/2024
MUPIROCIN 2%, 15G (TUBE)
07/31/2024
08/07/2024
TOPICAL
Apply Thinly On Affected Area
Bid
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: